The unfolded protein response is activated in the olfactory system in Alzheimer’s disease

• Published in: Acta neuropathologica communications 2020-07, Vol.8 (1), p.1-109, Article 109
• Main Authors: Murray, Helen C., Dieriks, Birger Victor, Swanson, Molly E. V., Anekal, Praju Vikas, Turner, Clinton, Faull, Richard L. M., Belluscio, Leonardo, Koretsky, Alan, Curtis, Maurice A.
• Format: Article
• Language: English
• Subjects: Advertising executives; Alzheimer's disease; Anterior olfactory nucleus; Antibodies; Apoptosis; Disease; eIF2α; Immunohistochemistry; Kinases; Labeling; Olfactory bulb; PERK; Proteins; Smell; Stains & staining; Unfolded protein response
• ISSN: 2051-5960; 2051-5960
• DOI: 10.1186/s40478-020-00986-7

Olfactory dysfunction is an early and prevalent symptom of Alzheimer’s disease (AD) and the olfactory bulb is a nexus of beta-amyloid plaque and tau neurofibrillary tangle (NFT) pathology during early AD progression. To mitigate the accumulation of misfolded proteins, an endoplasmic reticulum stress response called the unfolded protein response (UPR) occurs in the AD hippocampus. However, chronic UPR activation can lead to apoptosis and the upregulation of beta-amyloid and tau production. Therefore, UPR activation in the olfactory system could be one of the first changes in AD. In this study, we investigated whether two proteins that signal UPR activation are expressed in the olfactory system of AD cases with low or high amounts of aggregate pathology. We used immunohistochemistry to label two markers of UPR activation (p-PERK and p-eIF2α) concomitantly with neuronal markers (NeuN and PGP9.5) and pathology markers (beta-amyloid and tau) in the olfactory bulb, piriform cortex, entorhinal cortex and the CA1 region of the hippocampus in AD and normal cases. We show that UPR activation, as indicated by p-PERK and p-eIF2α expression, is significantly increased throughout the olfactory system in AD cases with low (Braak stage III-IV) and high-level (Braak stage V-VI) pathology. We further show that UPR activation occurs in the mitral cells and in the anterior olfactory nucleus of the olfactory bulb where tau and amyloid pathology is abundant. However, UPR activation is not present in neurons when they contain NFTs and only rarely occurs in neurons containing diffuse tau aggregates. We conclude that UPR activation is prevalent in all regions of the olfactory system and support previous findings suggesting that UPR activation likely precedes NFT formation. Our data indicate that chronic UPR activation in the olfactory system might contribute to the olfactory dysfunction that occurs early in the pathogenesis of AD.